Rhumbline Advisers

Filing Details

13F-HR/A • 2025-03-31
SEC
Report Date
2025-03-31
Filing Date
2025-05-29
Total Holdings
4,182
Total Value
106905259736
Accession Number
0001115418-25-000005
Form Type
13F-HR/A
CIK
0001115418
Manager Name
Rhumbline Advisers
Data Enrichment
81% identified
3,407 identified775 unidentified

Holdings

4,182 positions
Manager:
SEC
Search and click to pin securities to the top
Page 164 of 210
FUELCELL ENERGY INC
FCEL|35952H700
Shares:
32012(+21.1%)
Value:
$146.9M(-38.5%)
Townsquare Media, Inc.
TSQ|892231101
Shares:
18036(+23.2%)
Value:
$146.8M(+10.3%)
759673403
759673403
Shares:
14494(-3.7%)
Value:
$146.7M(+1.5%)
Kodiak Sciences Inc.
KOD|50015M109
Shares:
52274(+1.6%)
Value:
$146.6M(-71.4%)
STRATUS PROPERTIES INC
STRS|863167201
Shares:
8245(-0.3%)
Value:
$146.3M(-14.7%)
29265W207
29265W207
Shares:
18123(+1.6%)
Value:
$146.1M(+15.7%)
New Oriental Education & Technology Group Inc.
EDU|647581206
Shares:
3054(-37.2%)
Value:
$146.0M(-53.2%)
Solid Biosciences Inc.
SLDB|83422E204
Shares:
39422(-9.7%)
Value:
$145.9M(-16.5%)
EGAIN Corp
EGAN|28225C806
Shares:
29950(+4.4%)
Value:
$145.2M(-18.7%)
LINKBANCORP, Inc.
LNKB|53578P105
Shares:
21424(-6.0%)
Value:
$145.2M(-14.8%)
BRC Inc.
BRCC|05601U105
Shares:
69066(+3.5%)
Value:
$144.3M(-31.8%)
Adverum Biotechnologies, Inc.
ADVM|00773U207
Shares:
32999(+4.2%)
Value:
$144.2M(-2.5%)
Rapport Therapeutics, Inc.
RAPP|75383L102
Shares:
14358(+40.1%)
Value:
$144.0M(-20.8%)
Nkarta, Inc.
NKTX|65487U108
Shares:
78185(-3.7%)
Value:
$143.9M(-28.8%)
Editas Medicine, Inc.
EDIT|28106W103
Shares:
123850(-12.0%)
Value:
$143.7M(-19.6%)
Alector, Inc.
ALEC|014442107
Shares:
116635(+0.6%)
Value:
$143.4M(-34.5%)
C4 Therapeutics, Inc.
CCCC|12529R107
Shares:
89633(-10.4%)
Value:
$143.4M(-60.2%)
072743404
072743404
Shares:
5356(+146.7%)
Value:
$142.9M(+141.1%)
SONIDA SENIOR LIVING, INC.
SNDA|140475203
Shares:
6125(+37.8%)
Value:
$142.6M(+39.1%)
87089E100
87089E100
Shares:
3120
Value:
$142.3M